下一代抗菌纳米聚合物治疗细菌源性口腔慢性炎症性疾病
本文综述了基于聚合物纳米技术的下一代抗菌策略(NGAS)用于牙周炎和根尖周炎的潜在治疗。通过系统检索MEDLINE、Cochrane、EMBASE和Web of Science,识别出聚己内酯、聚乳酸-羟基乙酸共聚物和壳聚糖等纳米聚合物联合抗菌物质的研究。结论认为含抗菌化合物的聚合物纳米材料可作为潜在NGAS,但相对疗效尚不明确,因多数证据来自体外或临床前体内研究。
要点
- 聚合物纳米材料联合抗菌物质是治疗牙周炎和根尖周炎的潜在下一代抗菌策略。
- 常用纳米聚合物包括聚己内酯、聚乳酸-羟基乙酸共聚物和壳聚糖。
- 多数证据来自体外或临床前体内研究,相对疗效尚不明确。
核心结论
- 含抗菌化合物的聚合物纳米材料可被视为潜在的下一代抗菌策略,但其相对疗效尚不明确。
研究设计与样本
- 系统检索MEDLINE(PubMed)、Cochrane口腔健康组试验注册库、EMBASE和Web of Science,纳入聚合物纳米技术辅助抗菌策略治疗牙周和根尖周疾病的研究。
主要发现
- 牙周文献中识别出多种聚合物纳米颗粒、纳米纤维和纳米结构水凝胶联合抗菌物质。
- 最常用的纳米聚合物为聚己内酯、聚乳酸-羟基乙酸共聚物和壳聚糖。
- 最常用的抗菌物质为抗生素,也有金属离子、肽和天然产物被添加到纳米聚合物中。
临床怎么用
- 聚合物纳米材料联合抗菌物质可作为牙周炎和根尖周炎的潜在辅助抗菌策略,但需更多临床证据验证疗效。
局限性
- 大多数现有证据来自体外或临床前体内研究,相对疗效尚不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: 'Periodontitis' refers to periodontal destruction of connective tissue attachment and bone, in response to microorganisms forming subgingival biofilms on the root surface, while 'apical periodontitis' refers to periapical inflammatory processes occurring in response to microorganisms within the root canal system. The treatment of both diseases is based on the elimination of the bacterial challenge, though its predictability depends on the ability of disrupting these biofilms, what may need adjunctive antibacterial strategies, such as the next-generation antibacterial strategies (NGAS). From all the newly developed NGAS, the use of polymeric nanotechnology may pose a potential effective approach. Although some of these strategies have only been tested in vitro and in preclinical in vivo models, their use holds a great potential, and therefore, it is relevant to understand their mechanism of action and evaluate their scientific evidence of efficacy. OBJECTIVES: To explore NGAS based on polymeric nanotechnology used for the potential treatment of periodontitis and apical periodontitis. METHOD: A systemic search of scientific publications of adjunctive antimicrobial strategies using nanopolymers to treat periodontal and periapical diseases was conducted using The National Library of Medicine (MEDLINE by PubMed), The Cochrane Oral Health Group Trials Register, EMBASE and Web of Science. RESULTS: Different polymeric nanoparticles, nanofibres and nanostructured hydrogels combined with antimicrobial substances have been identified in the periodontal literature, being the most commonly used nanopolymers of polycaprolactone, poly(lactic-co-glycolic acid) and chitosan. As antimicrobials, the most frequently used have been antibiotics, though other antimicrobial substances, such as metallic ions, peptides and naturally derived products, have also been added to the nanopolymers. CONCLUSION: Polymeric nanomaterials containing antimicrobial compounds may be considered as a potential NGAS. Its relative efficacy, however, is not well understood since most of the existing evidence is derived from in vitro or preclinical in vivo studies.
引用
- Toledano-Osorio M, Osorio R, Bueno J, et al. Next-generation antibacterial nanopolymers for treating oral chronic inflammatory diseases of bacterial origin. Int Endod J. 2024. PMID: 38340038. doi:10.1111/iej.14040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。